Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors
Authors:
Open Access
- 3 February 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 39 (3) , 151-157
Abstract
This study was undertaken to identify the factors predictive of radiation pneumonitis (RP) in 69 non-small cell lung cancer patients treated with thoracic radiation therapy only by 3 Gy fractions. A total of 69 patients who received only RT in daily 3 Gy were included in this study. Grade ≥3 RP was defined as an RP event. The cumulative incidence of RP was estimated and the correlations of the development of RP with the potential predictors were determined. The cumulative incidence of events was 17.1% at 12 months. By univariate analysis, all clinical factors [age, performance status, weight loss, pre-RT forced expiratory volume in 1 s, tumour location, stage, RT dose and clinical target volume] were not associated with the risk of Grade ≥3 RP; however, all dosimetric factors [V5–50 and mean lung dose (MLD)] closely correlated with the development of RP. The receiver-operative characteristics (ROC) analysis revealed that MLD was the best predictors of Grade ≥3 RP (area under curve ROC = 0.937). By multivariate analysis, MLD was the only significant factor to be predictive of RP risk: the probability of Grade ≥3 RP was 3.7% when MLD ≤ 16.1 Gy and 78.4% when MLD > 16.1 Gy. Dosimetric parameters were valuable in predicting the development of RP.Keywords
This publication has 17 references indexed in Scilit:
- High-dose Thoracic Radiation Therapy at 3.0 Gy/Fraction in Inoperable Stage I/II Non-small Cell Lung CancerJapanese Journal of Clinical Oncology, 2008
- Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlatesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non–small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose–volume histogram analysis and comparison with conventional chemoradiationInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2006
- Dose-volumetric Parameters for Predicting Severe Radiation Pneumonitis after Three-dimensional Conformal Radiation Therapy for Lung CancerRadiology, 2005
- Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2005
- To the EditorRadiotherapy and Oncology, 2005
- CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancerLung Cancer, 2004
- Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapyRadiotherapy and Oncology, 2004
- Factors predicting radiation pneumonitis in lung cancer patients: a retrospective studyRadiotherapy and Oncology, 2003